Objective-To determine whether serum soluble interleukin 2 receptor concentrations are related to disease activity in atopic eczema.
Introduction
Atopic eczema is a common skin disorder that usually runs a chronic course with acute episodes and is often associated with hay fever, asthma, or a family history of atopic disease. The pathogenesis has not been defined, but genetic, immunological, and biochemical factors have all been implicated. Though exacerbations may be related to allergens, drugs, and stress, it remains an unpredictable disease, and there are probably other unidentified stimuli.
The association of eczema with other atopic diseases in which IgE has been implicated suggests a role for hypersensitivity. Most The front and back of the body were each divided into six sections and scored from 0 to 3 for erythema, vesiculation, excoriation, and lichenification. In addition, the amount of skin affected was scored from 1-6. The maximum score for each section was Figure 3 shows the values in the four patients who had the highest concentrations on admission. Two showed rapid falls in concentrations with concomitant clinical improvement leading to early discharge. The other two showed delayed falls and required longer One patient who had a slow reduction in the concentration of soluble interleukin 2 receptor from 950 U/ml also had a slow clinical improvement but was discharged from hospital. After two weeks her eczema flared, and on readmission her soluble interleukin 2 receptor concentration was again raised at 920 U/mI. Over the subsequent days it fell to 550 U/ml but three days later, on the day of discharge, had risen to 670 U/ml. She requifed yet another admission for treatment seven days later, suggesting that her previous rise before discharge was of some predictive value.
Discussion
A laboratory test to monitor disease activity in atopic eczema would be useful. Previously it was thought that the serum IgE titre might be informative because it is raised in most patients with atopic eczema.' Some investigators have found a correlation between IgE titre and clinical disease," but others have reported that it is often unchanged after successful topical treatment. 4 The lymphokine interleukin 2 has a major role in the activation of T cells, resulting in further lymphokine production and cellular proliferation. It Steroids are known to suppress synthesis of interleukin 2 and its receptor24 and inhibit T cell proliferation.25 Production of interleukin 2 in lymphocytes from patients resistant to steroids is also fairly resistant to steroids.26 Hydrocortisone suppresses not only production of interleukin 2 receptor but also the number of receptors already on the cell surface.27 These findings suggest that falling receptor concentrations in our patients could have been related to topical steroids. Before admission, however, when their soluble interleukin 2 receptor concentrations were highest, all our patients were using a steroid preparation of similar potency to that used in hospital.
As well as being a useful marker of immune activity soluble interleukin 2 receptor, by binding interleukin 2, may have an immunoregulatory role with inhibitory effects on T cell activation.928 This could contribute to defective cell mediated immunity in atopic eczema29 and other inflammatory diseases. The cellular events that give rise to the lesions of atopic eczema remain unknown, but we suggest that raised soluble interleukin 2 receptor concentrations reflect activation of immunopathogenic mechanisms contributing to exacerbation of the disease. Clinically, the concentration seems potentially useful for assessing responses to new treatments and may even have prognostic value.
